BILATERAL SIMULTANEOUS TOTAL KNEE ARTHROPLASTY VS. STAGED
In the absence of reliable evidence, it is the opinion of the workgroup that simultaneous bilateral total knee arthroplasty (TKA) could be performed vs. staged (>90 days) bilateral TKA in appropriately selected patients but should be performed with caution and should be avoided with patients who are at high risk of cardiopulmonary complications.

Rationale

This recommendation has been downgraded due to the potential harms to the patient. In the limited evidence available, no difference in overall complication rates for patients who underwent bilateral simultaneous TKA versus stage TKA is found. Several studies demonstrate lower hemoglobin (Feng 2019) in simultaneous TKA group, but there are mixed findings regarding increased blood transfusion (Feng 2019, Wan 2021, Bohn 2016). Some studies found increased risk of PE with bilateral simultaneous TKA (Hadley 2017, Bohm 2016) though others found no difference in the compared groups (Goyal 2020, Arslan 2018, Zhao 2015). When specifically comparing bilateral simultaneous versus staged (excluding unilateral TKA), no mortality difference has been reported (Yoon 2010).

In the limited evidence available, findings are consistent that there are no functional outcome differences between simultaneous and staged bilateral TKA (Goyal 2020, Feng 2019).

Advantages to simultaneous bilateral TKA include cost savings (Wan 2021), decreased overall length of stay (Feng, 2020, Wan 2021, Kahlenberg 2021, Siedlecki 2018).

Benefits/ Harms of Implementation

Bilateral simultaneous TKA may be preferred for some patients with bilateral advanced knee osteoarthritis. While bilateral simultaneous TKA has shown to have increased risks when compared to unilateral TKA in recent literature (Warren 2021), multiple low-quality studies (Poultisides 2015, Seol 2016, Bohm 2016) have found adverse effects, including total adverse effects, in favor bilateral simultaneous TKA in comparison to bilateral staged TKA.

Cost Effectiveness / Resource Utilization

Limited evidence suggests bilateral simultaneous total knee arthroplasty is cost saving.

Future Research

This recommendation is based on limited evidence from retrospective studies and limited power prospective series, and analyses thereof. Well-designed large prospective or randomized trials will further the understanding of specific criteria for patients choosing between either staged or simultaneous bilateral total knee arthroplasty